Skip to main content
All lobbying filings

ORCHARD THERAPEUTICS NORTH AMERICA

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

 Filing 2nd Quarter - Amendment
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $430,000.00 expenses · posted Mar 13, 2026

Official filing document

 Bills named in this filing 2
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
 Lobbying activity 2
Health Issues

Appropriations for Newborn Screening HR 1262/ S 932 - Give Kids a Chance Act of 2025

Medicare/Medicaid

Medicaid Value-Based Payments for Patients (MVP) Act HR 1509/ S 752 - Accelerating Kids' Access to Care Act & Give Kids a Chance Act 2025

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem